Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Human antibodies for immunotherapy development generated via a human B cell hybridoma technology.

Li J, Sai T, Berger M, Chao Q, Davidson D, Deshmukh G, Drozdowski B, Ebel W, Harley S, Henry M, Jacob S, Kline B, Lazo E, Rotella F, Routhier E, Rudolph K, Sage J, Simon P, Yao J, Zhou Y, Kavuru M, Bonfield T, Thomassen MJ, Sass PM, Nicolaides NC, Grasso L.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3557-62. Epub 2006 Feb 27.

2.

Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.

Ames RS, Tornetta MA, McMillan LJ, Kaiser KF, Holmes SD, Appelbaum E, Cusimano DM, Theisen TW, Gross MS, Jones CS, et al.

J Immunol. 1995 Jun 15;154(12):6355-64.

PMID:
7759873
3.

Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci.

He Y, Honnen WJ, Krachmarov CP, Burkhart M, Kayman SC, Corvalan J, Pinter A.

J Immunol. 2002 Jul 1;169(1):595-605.

4.

Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.

Ainai A, Kawase T, Ida A, Maeda Y, Ohba H, Ikeda Y, Sato H, Takahashi M, Chiba J.

Hum Antibodies. 2006;15(4):139-54.

PMID:
17522436
7.

Production of anti-tumor human monoclonal antibodies using different approaches.

Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG.

Hum Antibodies Hybridomas. 1993 Jan;4(1):2-8.

PMID:
8381684
8.

Molecular characterization of human B domain-specific anti-factor VIII monoclonal antibodies generated in transgenic mice.

Lavigne-Lissalde G, Lacroix-Desmazes S, Wootla B, Tarrade C, Schved JF, Kaveri SV, Granier C, Villard-Saussine S.

Thromb Haemost. 2007 Jul;98(1):138-47.

PMID:
17598006
9.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
10.

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.

Funaro A, Gribaudo G, Luganini A, Ortolan E, Lo Buono N, Vicenzi E, Cassetta L, Landolfo S, Buick R, Falciola L, Murphy M, Garotta G, Malavasi F.

BMC Biotechnol. 2008 Nov 12;8:85. doi: 10.1186/1472-6750-8-85.

11.

Generation of high-affinity antibody against T cell-dependent antigen in the Ganp gene-transgenic mouse.

Sakaguchi N, Kimura T, Matsushita S, Fujimura S, Shibata J, Araki M, Sakamoto T, Minoda C, Kuwahara K.

J Immunol. 2005 Apr 15;174(8):4485-94.

12.

Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.

Kametani Y, Shiina M, Katano I, Ito R, Ando K, Toyama K, Tsukamoto H, Matsumura T, Saito Y, Ishikawa D, Taki T, Ito M, Imai K, Tokuda Y, Kato S, Tamaoki N, Habu S.

Exp Hematol. 2006 Sep;34(9):1240-8.

PMID:
16939817
13.

Antigen-specific human antibodies from mice comprising four distinct genetic modifications.

Lonberg N, Taylor LD, Harding FA, Trounstine M, Higgins KM, Schramm SR, Kuo CC, Mashayekh R, Wymore K, McCabe JG, et al.

Nature. 1994 Apr 28;368(6474):856-9.

PMID:
8159246
14.

[Monoclonal antibodies produced by human-human hybridomas].

Chida J.

Gan To Kagaku Ryoho. 1984 Jan;11(1):157-64. Japanese.

PMID:
6607711
15.

Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells.

Dubrot J, Portero A, Orive G, Hernández RM, Palazón A, Rouzaut A, Perez-Gracia JL, Hervás-Stubbs S, Pedraz JL, Melero I.

Cancer Immunol Immunother. 2010 Nov;59(11):1621-31. doi: 10.1007/s00262-010-0888-z. Epub 2010 Jul 6.

PMID:
20607237
16.

Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.

Khademi F, Mostafaie A, Parvaneh S, Gholami Rad F, Mohammadi P, Bahrami G.

Int Immunopharmacol. 2017 Feb;43:23-32. doi: 10.1016/j.intimp.2016.11.035. Epub 2016 Dec 7.

PMID:
27939822
17.

Increased yields of IgG2a- and IgG3-secreting hybridomas after fusion of B cells from mice with autoimmune diseases.

Yin BW, Wong GY, Lloyd KO, Oettgen HF, Welt S.

J Immunol Methods. 1991 Nov 22;144(2):165-73.

PMID:
1960413
18.

Hybridoma technology for the generation of monoclonal antibodies.

Zhang C.

Methods Mol Biol. 2012;901:117-35. doi: 10.1007/978-1-61779-931-0_7.

PMID:
22723097
19.

Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris.

Proby CM, Ota T, Suzuki H, Koyasu S, Gamou S, Shimizu N, Wahl JK, Wheelock MJ, Nishikawa T, Amagai M.

Br J Dermatol. 2000 Feb;142(2):321-30.

PMID:
10730768

Supplemental Content

Support Center